Hi Joe, Morning newspaper:
Globes says Dimethaid kills U.K. ointment deal
Dimethaid Research Inc DMX
Shares issued 45,494,000 Jun 14 close $3.46
Mon 17 Jun 2002 In the News
The Globe and Mail reports in its Saturday, June 15, edition that Dimethaid
Research of Markham, Ont., says it has ended a British sales and marketing
deal with Provalis Healthcare for distribution of Pennsaid, an ointment to
treat arthritis. The Globe's Briefing column reports that Dimethaid in
January, 2001, awarded the Provalis PLC unit exclusive rights to market and
distribute the drug in Britain, where seven million people suffer from
osteoarthritis. Provalis was expected to meet minimum sales targets by
March. "We fully expected Pennsaid to be achieving greater sales and market
penetration in the United Kingdom than has been the case to date,"
Dimethaid said in a release. Dimethaid stock slipped four cents to finish
Friday at $3.46, sixteen cents ahead of its 52-week low, on the Toronto
Stock Exchange Friday. The stock has a 52-week high of $6.85.
(c) Copyright 2002 Canjex Publishing Ltd. stockwatch.com |
